Predictors of poor kidney outcome in children with C3 glomerulopathy
- Tekcan, Demet
- SOYLU, ALPER
- YILMAZ, DİLEK
- TABEL, YILMAZ
- Yildirim, Zeynep Y.
- PINARBAŞI, AYŞE SEDA
- DURSUN, İSMAİL
- GÖKCE, İBRAHİM
- ÇOMAK, ELİF
- SAYGILI, Seha Kamil
- DÖNMEZ, OSMAN
- Melek, Engin
- cicek, Neslihan
- BAHAT ÖZDOĞAN, ELİF
- KOYUN, MUSTAFA
- CANPOLAT, Nur
- Aksu, Bagdagul
- celakil, Mehtap Ezel
- Tasdemir, Mehmet
- Benzer, Meryem
- ozcelik, Gul
- BAKKALOĞLU EZGÜ, SEVCAN AZİME
- DÜŞÜNSEL, Ruhan
- TORUN BAYRAM, MERAL
Publication date
May 2021
DOI Publisher
Springer Science and Business Media LLCAbstract
Background C3 glomerulopathy (C3G) is characterized by heterogeneous clinical presentation, outcome, and predominant C3 accumulation in glomeruli without significant IgG. There is scarce outcome data regarding childhood C3G. We describe clinical and pathological features, treatment and outcomes, and risk factors for progression to chronic kidney disease stage 5 (CKD5) in the largest pediatric series with biopsy-proven C3G
Add to ORKG